Scientia Advisors Review: Life Science Tools industry
October 21, 2009
Scientia Advisors, my client, today released a comprehensive review of the Life Science Tools Industry.
Among the key points:
- It’s a complex arena, likely to remain largely in the US for the next few years, despite intense growth in the Asia-Pacific Region.
- The industry is fragmented despite dominance by just a handful of companies. Leading companies face competition as smaller companies consolidate.
- Scientia projects combined annual growth of eight per cent through 2012 and beyond.
- Growth is expected for cell-based assays and cell-isolation technologies; live cell analysis; cell-based assays for drug discovery research and development; kinases, RNAI and biomarker research, and cell preparation and manipulation.
The review is available for download from Scientia’s Web site at www.scientiaadv.com.
–Anita M. Harris
HarrisComBlog is a publication of the Harris Communications Group of Cambridge, MA. We also publish New Cambridge Observer.
